136 related articles for article (PubMed ID: 33607165)
1. Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia.
Vivancos M; Fanelli R; Besserer-Offroy É; Beaulieu S; Chartier M; Resua-Rojas M; Mona CE; Previti S; Rémond E; Longpré JM; Cavelier F; Sarret P
Behav Brain Res; 2021 May; 405():113189. PubMed ID: 33607165
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.
Eiselt E; Gonzalez S; Martin C; Chartier M; Betti C; Longpré JM; Cavelier F; Tourwé D; Gendron L; Ballet S; Sarret P
ACS Chem Neurosci; 2019 Nov; 10(11):4535-4544. PubMed ID: 31589400
[TBL] [Abstract][Full Text] [Related]
3. Insightful Backbone Modifications Preventing Proteolytic Degradation of Neurotensin Analogs Improve NT
Previti S; Vivancos M; Rémond E; Beaulieu S; Longpré JM; Ballet S; Sarret P; Cavelier F
Front Chem; 2020; 8():406. PubMed ID: 32582624
[TBL] [Abstract][Full Text] [Related]
4. Pain relief devoid of opioid side effects following central action of a silylated neurotensin analog.
Tétreault P; Besserer-Offroy É; Brouillette RL; René A; Murza A; Fanelli R; Kirby K; Parent AJ; Dubuc I; Beaudet N; Côté J; Longpré JM; Martinez J; Cavelier F; Sarret P
Eur J Pharmacol; 2020 Sep; 882():173174. PubMed ID: 32534076
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity.
Roussy G; Dansereau MA; Baudisson S; Ezzoubaa F; Belleville K; Beaudet N; Martinez J; Richelson E; Sarret P
Mol Pain; 2009 Jul; 5():38. PubMed ID: 19580660
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog.
Chartier M; Desgagné M; Sousbie M; Rumsby C; Chevillard L; Théroux L; Haroune L; Côté J; Longpré JM; Boudreault PL; Marsault É; Sarret P
Biomed Pharmacother; 2021 Sep; 141():111861. PubMed ID: 34229249
[TBL] [Abstract][Full Text] [Related]
7. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
Smith KE; Boules M; Williams K; Richelson E
Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
[TBL] [Abstract][Full Text] [Related]
8. Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors.
Sarret P; Esdaile MJ; Perron A; Martinez J; Stroh T; Beaudet A
J Neurosci; 2005 Sep; 25(36):8188-96. PubMed ID: 16148226
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin Analogues.
Fanelli R; Besserer-Offroy É; René A; Côté J; Tétreault P; Collerette-Tremblay J; Longpré JM; Leduc R; Martinez J; Sarret P; Cavelier F
J Med Chem; 2015 Oct; 58(19):7785-95. PubMed ID: 26348111
[TBL] [Abstract][Full Text] [Related]
10. Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model.
Roussy G; Dansereau MA; Doré-Savard L; Belleville K; Beaudet N; Richelson E; Sarret P
J Neurochem; 2008 May; 105(4):1100-14. PubMed ID: 18182046
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain.
Guillemette A; Dansereau MA; Beaudet N; Richelson E; Sarret P
Eur J Pain; 2012 Apr; 16(4):473-84. PubMed ID: 22396077
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain.
Brouillette RL; Besserer-Offroy É; Mona CE; Chartier M; Lavenus S; Sousbie M; Belleville K; Longpré JM; Marsault É; Grandbois M; Sarret P
Pharmacol Res; 2020 May; 155():104750. PubMed ID: 32151680
[TBL] [Abstract][Full Text] [Related]
13. Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.
Chartier M; Desgagné M; Sousbie M; Côté J; Longpré JM; Marsault E; Sarret P
J Med Chem; 2021 Feb; 64(4):2110-2124. PubMed ID: 33538583
[TBL] [Abstract][Full Text] [Related]
14. The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.
Smith KE; Boules M; Williams K; Fauq AH; Richelson E
Behav Brain Res; 2011 Oct; 224(2):344-9. PubMed ID: 21718721
[TBL] [Abstract][Full Text] [Related]
15. Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management.
Previti S; Desgagné M; Tourwé D; Cavelier F; Sarret P; Ballet S
J Pept Sci; 2023 Jun; 29(6):e3471. PubMed ID: 36539999
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.
Demeule M; Beaudet N; Régina A; Besserer-Offroy É; Murza A; Tétreault P; Belleville K; Ché C; Larocque A; Thiot C; Béliveau R; Longpré JM; Marsault É; Leduc R; Lachowicz JE; Gonias SL; Castaigne JP; Sarret P
J Clin Invest; 2014 Mar; 124(3):1199-213. PubMed ID: 24531547
[TBL] [Abstract][Full Text] [Related]
17. Involvement of NTS2 receptors in stress-induced analgesia.
Lafrance M; Roussy G; Belleville K; Maeno H; Beaudet N; Wada K; Sarret P
Neuroscience; 2010 Mar; 166(2):639-52. PubMed ID: 20035838
[TBL] [Abstract][Full Text] [Related]
18. NT79: A novel neurotensin analog with selective behavioral effects.
Boules M; Liang Y; Briody S; Miura T; Fauq I; Oliveros A; Wilson M; Khaniyev S; Williams K; Li Z; Qi Y; Katovich M; Richelson E
Brain Res; 2010 Jan; 1308():35-46. PubMed ID: 19874804
[TBL] [Abstract][Full Text] [Related]
19. Highly potent neurotensin analog that causes hypothermia and antinociception.
Tyler-McMahon BM; Stewart JA; Farinas F; McCormick DJ; Richelson E
Eur J Pharmacol; 2000 Feb; 390(1-2):107-11. PubMed ID: 10708713
[TBL] [Abstract][Full Text] [Related]
20. Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine.
Boules M; Johnston H; Tozy J; Smith K; Li Z; Richelson E
Behav Pharmacol; 2011 Sep; 22(5-6):573-81. PubMed ID: 21691202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
